EOLS · Evolus, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-03-20 | Avelar Rui |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards. The shares were sold in multiple trades at prices ranging from $4.7498 to $4.7701. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
3,119 |
| 2026-03-20 | MOATAZEDI DAVID |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards. The shares were sold in multiple trades at prices ranging from $4.7498 to $4.775. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
13,669 |
| 2026-03-17 | Avelar Rui |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of multiple PSU and restricted stock unit awards. The shares were sold in multiple trades at prices ranging from $4.8874 to $4.945. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
29,996 |
| 2026-03-17 | MOATAZEDI DAVID |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of multiple PSU and restricted stock unit awards. The shares were sold in multiple trades at prices ranging from $4.8874 to $5.015. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
116,720 |
| 2026-03-16 | Avelar Rui |
See Remarks |
Convert↓
Filing footnotes — Performance Restricted Stock Units (Direct)
As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures. |
Performance Restricted Stock Units
|
8,804 |
| 2026-03-16 | MOATAZEDI DAVID |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
As previously reported, on February 7, 2024, the Reporting Person was granted 134,977 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 134,977 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 67,489 shares of the Issuer's common stock. The remaining 67,488 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures. |
Common Stock
|
67,489 |
| 2026-03-16 | Avelar Rui |
See Remarks |
Convert↑
Filing footnotes — Common Stock (Direct)
As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures. |
Common Stock
|
8,804 |
| 2026-03-16 | MOATAZEDI DAVID |
Director |
Convert↓
Filing footnotes — Performance Restricted Stock Units (Direct)
As previously reported, on February 7, 2024, the Reporting Person was granted 134,977 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 134,977 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 67,489 shares of the Issuer's common stock. The remaining 67,488 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures. |
Performance Restricted Stock Units
|
67,489 |
| 2026-02-17 | Mitchell Tatjana |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control). |
Stock Option (Right to Buy)
|
177,471 |
| 2026-02-17 | MOATAZEDI DAVID |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable upon settlement of restricted stock units (RSUs). Each RSU represents the right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control). |
Common Stock
|
313,212 |
| 2026-02-17 | GILL DAVID N |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common Stock
|
45,559 |
| 2026-02-17 | Malik Vikram |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common Stock
|
45,559 |
| 2026-02-17 | Stewart Brady |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common Stock
|
45,559 |
| 2026-02-17 | Parschauer Karah Herdman |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common Stock
|
45,559 |
| 2026-02-17 | White Albert G III |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common Stock
|
45,559 |
| 2026-02-17 | Avelar Rui |
See Remarks |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control). |
Stock Option (Right to Buy)
|
138,649 |
| 2026-02-17 | Mitchell Tatjana |
Chief Financial Officer |
Award↑
Filing footnotes — Performance Restricted Stock Units (Direct)
Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs. The number of shares issuable upon vesting is based on performance against pre-established financial metrics and relative total shareholder return (TSR) over a three-year performance period ending December 31, 2028. Subject to certification of performance results, any earned PSUs vest following the performance period. |
Performance Restricted Stock Units
|
121,489 |
| 2026-02-17 | Avelar Rui |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable upon settlement of restricted stock units (RSUs). Each RSU represents the right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control). |
Common Stock
|
94,913 |
| 2026-02-17 | Mitchell Tatjana |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable upon settlement of restricted stock units (RSUs). Each RSU represents the right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control). |
Common Stock
|
121,489 |
| 2026-02-17 | MOATAZEDI DAVID |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control). |
Stock Option (Right to Buy)
|
457,541 |
| 2026-02-17 | Avelar Rui |
See Remarks |
Award↑
Filing footnotes — Performance Restricted Stock Units (Direct)
Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs. The number of shares issuable upon vesting is based on performance against pre-established financial metrics and relative total shareholder return (TSR) over a three-year performance period ending December 31, 2028. Subject to certification of performance results, any earned PSUs vest following the performance period. |
Performance Restricted Stock Units
|
94,913 |
| 2026-02-17 | MOATAZEDI DAVID |
Director |
Award↑
Filing footnotes — Performance Restricted Stock Units (Direct)
Each performance-based restricted stock unit (PSU) represents the right to receive, upon vesting, up to 200% of the target number of shares of common stock of the issuer. The number of shares issuable upon vesting is based on performance against pre-established financial metrics and relative total shareholder return (TSR) over a three-year performance period ending December 31, 2028. Subject to certification of performance results, any earned PSUs vest following the performance period. |
Performance Restricted Stock Units
|
626,424 |
| 2025-12-22 | Avelar Rui |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units. |
Common Stock
|
2,261 |
| 2025-12-22 | MOATAZEDI DAVID |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. |
Common Stock
|
10,539 |
| 2025-09-08 | Mitchell Tatjana |
Chief Financial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2025-09-08 | Mitchell Tatjana |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with one-half of the RSU vesting on each of the third and fourth anniversary of September 8, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
Common Stock
|
104,603 |
| 2025-09-08 | Mitchell Tatjana |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of September 8, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
Stock Option (Right to Buy)
|
143,403 |
| 2025-08-22 | Yamagishi-Dressler Tomoko |
Chief Marketing Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. |
Common Stock
|
5,722 |
| 2025-08-15 | Stewart Brady |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The shares were purchased in multiple trades at prices ranging from $6.7699 to $6.82. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
30,000 |
| 2025-06-16 | MOATAZEDI DAVID |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold in multiple trades at prices ranging from $9.82 to $10.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
16,582 |
| 2025-06-13 | MOATAZEDI DAVID |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold in multiple trades at prices ranging from $10.00 to $10.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
111,323 |
| 2025-06-09 | White Albert G III |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The shares were purchased in multiple trades at prices ranging from $9.40 to $9.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
20,000 |
| 2025-05-13 | Beaver Sandra |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units. |
Common Stock
|
6,494 |
| 2025-05-12 | MOATAZEDI DAVID |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units. |
Common Stock
|
15,787 |
| 2025-05-12 | Avelar Rui |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units. |
Common Stock
|
3,385 |
| 2025-03-27 | MOATAZEDI DAVID |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. |
Common Stock
|
6,251 |
| 2025-03-18 | Avelar Rui |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. The shares were sold in multiple trades at prices ranging from $13.174 to $13.256. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
27,904 |
| 2025-03-18 | MOATAZEDI DAVID |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. The shares were sold in multiple trades at prices ranging from $13.1765 to $13.256. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
103,376 |
| 2025-03-18 | Yamagishi-Dressler Tomoko |
Chief Marketing Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. The shares were sold in multiple trades at prices ranging from $13.1807 to $13.256. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
4,536 |
| 2025-03-18 | Beaver Sandra |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units. The shares were sold in multiple trades at prices ranging from $13.185 to $13.256. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
8,996 |
| 2025-03-12 | Parschauer Karah Herdman |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold in multiple trades at prices ranging from $12.98 to $13.025. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
12,888 |
| 2025-03-07 | Stewart Brady |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of March 7, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common Stock
|
7,364 |
| 2025-03-07 | Yamagishi-Dressler Tomoko |
Chief Marketing Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
Common Stock
|
17,832 |
| 2025-03-07 | Avelar Rui |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
Common Stock
|
23,776 |
| 2025-03-07 | Avelar Rui |
See Remarks |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
Stock Option (Right to Buy)
|
33,875 |
| 2025-03-07 | MOATAZEDI DAVID |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
Stock Option (Right to Buy)
|
135,925 |
| 2025-03-07 | Stewart Brady |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
Stock Option (Right to Buy)
|
11,146 |
| 2025-03-07 | Malik Vikram |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
Stock Option (Right to Buy)
|
11,146 |
| 2025-03-07 | Beaver Sandra |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. |
Common Stock
|
35,663 |
| 2025-03-07 | BLANK SIMONE |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of March 7, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Common Stock
|
7,364 |